International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
An International Open Access Journal Devoted to General Medicine.
Perioperative neurocognitive disorders (PNDs) represent a spectrum of cognitive impairments that occur in association with anesthesia and surgery. A multidisciplinary consensus working group in 2018 recommended the term PND as an overarching classification that includes pre-existing cognitive impairment, postoperative delirium, delayed neurocognitive recovery, and postoperative neurocognitive disorder (1). This updated nomenclature aligns perioperative cognitive research with Diagnostic and Statistical Manual of Mental Disorders-5 neurocognitive disorder terminology and aims to standardize the description of cognitive changes occurring before or following surgery (2).
Postoperative cognitive dysfunction (POCD), a term historically used in perioperative research, refers to a measurable decline in cognitive domains such as memory, attention, and executive function following surgery and anesthesia (1). It is prevalent in older patients and has been increasingly observed after major surgeries, including cardiac surgery (1,3). The incidence of POCD following cardiac surgery is 10-40% of patients at 6 weeks post-surgery, and recovery is not always complete; ~45% of these patients achieve full recovery within 1 year (1). POCD is associated with delayed surgical recovery, prolonged hospital stays, impaired activities of daily living, and a lower likelihood of independent living (4). For example, patients developing POCD following cardiac surgery have over twice the relative risk of death (~2.04) compared with non-POCD patients and experience an additional average hospital stay of 1-2 days (4). These findings underscore the health costs and morbidity associated with POCD in patients undergoing cardiac surgery. As populations age and more cardiac surgery is performed, the morbidity burden from POCD is expected to rise.
Accurate POCD identification relies on standardized neurocognitive testing (1,4). A comprehensive battery covering multiple cognitive domains is ideal, but in practice, simpler screening tools are typically used. The most widely used brief cognitive test in perioperative literature is the Mini-Mental State Examination (MMSE) (5). The 30-point MMSE is applied to measure global cognitive function (orientation, memory, language, visuospatial), but was not designed to detect the more subtle changes of POCD (6). The MMSE has limitations as a POCD screen: it is not sensitive to mild impairment and under-identifies cognitive decline in surgical patients (7). For example, 15% of elderly patients were classified as cognitively impaired using the MMSE (cutoff <24), whereas 33% were identified as impaired when applying the more stringent Montreal Cognitive Assessment criteria (6-7). Similarly, poor sensitivity and lack of validated cutoffs have been found in other analyses for perioperative cognitive screening using MMSE (6-7). Studies relying on the MMSE may underestimate the true incidence of POCD, and comparisons between trials are difficult because different studies use different cognitive assessment tools.
Variations in reported POCD incidence have arisen from differences in testing procedures (instruments used, follow-up timing, and scoring criteria) (7-9). To the best of our knowledge, few studies have employed a consistent tool such as the MMSE to compare cognitive outcomes, particularly in cardiac surgery, directly (10-16). Therefore, the present systematic review and meta-analysis focusing on MMSE-based cognitive outcomes following cardiac surgery aimed to quantify changes in MMSE scores from preoperative baseline to postoperative follow-up among patients undergoing cardiac surgery, explore study-level factors associated with variability in cognitive outcomes, and evaluate the methodological characteristics of MMSE use across studies.
The present systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA 2020) guidelines (9). The study methods, inclusion criteria, and analysis plan were defined a priori before the literature search and data extraction.
MEDLINE/PubMed (pubmed.ncbi.nlm.nih.gov/), Embase (https://www.embase.com/), Cumulative Index to Nursing & Allied Health Literature (about.ebsco.com/products/research-databases/cinahl-database), the Cochrane Library (https://www.cochranelibrary.com/), PsycINFO (https://www.apa.org/pubs/databases/psycinfo), Web of Science (https://mjl.clarivate.com/home), and Scopus (https://www.scopus.com/sources) were searched for relevant literature from inception until May 2025 without regard to date or language. Search terms (Data S1) for ‘cardiac surgery’ [such as coronary artery bypass grafting (CABG), valve, or aortic surgery], ‘postoperative cognitive dysfunction’, and ‘Mini-Mental State Examination’ combined keywords and MeSH/Emtree terms. The reference lists of relevant reviews, dissertations, and conference proceedings were also searched.
Titles, abstracts, and full texts were independently screened by two reviewers against the predefined inclusion criteria. Inter-rater agreement during the screening process was assessed using Cohen's κ statistic after the initial title-abstract screening stage to quantify reviewer consistency. Any discrepancies were resolved through discussion or consultation with a third reviewer.
The inclusion criteria for the studies were as follows: i) Adult patients (age ≥18 years) undergoing cardiac surgery (CABG, valve, or aortic surgery); ii) cognitive function assessed using the MMSE both before and after surgery; iii) sufficient data reported (mean and SD or change scores) to calculate the standardized mean difference (SMD) and iv) original clinical studies (randomized trials or observational cohort studies).
Studies that did not use the MMSE for cognitive assessment, case reports, reviews, pediatric populations, or non-cardiac procedures (thoracic surgery, cardiac transplantation, or transcatheter valve replacement) were excluded. No restriction on publication year was applied.
Because included studies reported postoperative MMSE assessments at different follow-up intervals, data were extracted from the longest postoperative follow-up reported in each study when multiple time points were available. When studies reported several clinically distinct follow-up windows (early and late postoperative assessments), these were considered separate comparisons in the meta-analysis provided that independent summary statistics were available.
For subgroup analyses, patients were categorized as having POCD or not (non-POCD) according to the definitions reported in the original studies. In the perioperative literature, POCD is generally defined as a decline in cognitive performance relative to the patient's preoperative baseline measured using neuropsychological tests (2). However, there is currently no universally standardized diagnostic threshold, and studies typically employ different statistical approaches to determine cognitive decline (decreases of ≥1-2 SD from baseline performance, percentage decline in test scores, or composite indices derived from multiple cognitive tests) (1). POCD classification was therefore based on the criteria used in the original publications, which typically relied on postoperative deterioration in cognitive test performance, assessed using the MMSE or broader neuropsychological test batteries, relative to baseline values. Because diagnostic thresholds, testing batteries, and timing of postoperative assessments vary across studies, study-specific definitions were used rather than attempting to retrospectively standardize the classification using a single cutoff, which would not have been feasible with the available summary data (9).
Data were independently extracted by two investigators using a pre-piloted standardized form. Extracted variables included study design (prospective or retrospective; single-center or multicenter), country and setting, sample size, patient demographic characteristics (age and sex distribution), type of cardiac surgery, and timing of MMSE assessment. For each eligible comparison, the number of participants and the mean MMSE scores at baseline and postoperative time points or the reported change in MMSE when available were extracted.
When information was missing or unclear, attempts were made to contact the study authors for clarification. Any discrepancies in data extraction were resolved through discussion until consensus was reached. In addition, key study characteristics, including differences in surgical procedures, follow-up intervals, and study design, were recorded to facilitate interpretation of heterogeneity across studies.
A total of two reviewers independently evaluated methodological quality using the Critical Appraisal Skills Programme (CASP) checklist for cohort studies (8). The CASP tool includes 12 items evaluating study validity, methodological rigor, and relevance across domains such as selection bias, measurement of outcomes, confounding control, and applicability. Each item was scored as ‘yes’, ‘no’, or ‘unclear’. Studies were categorized according to the number of criteria fulfilled as follows: ≥10, good quality; 7-9, fair quality, and ≤6, low quality. Disagreements were resolved through discussion until a consensus was reached.
All meta-analytic computations were conducted using Comprehensive Meta-Analysis software, version 4 (Biostat, Inc.). The effect size for postoperative change in cognitive performance was estimated using SMD (Hedges' g) with corresponding 95% confidence intervals (CIs). Effect sizes were calculated from the reported preoperative and postoperative mean MMSE for each cohort. This approach standardizes the mean difference using the pooled SD of the two measurements and therefore does not require explicit imputation of the within-subject association between pre- and postoperative scores. Because the primary studies did not consistently report change-score variances or pre-post association, no fixed correlation coefficient was assumed in the analysis. Where only medians with ranges or interquartile ranges were reported, means and SD were estimated using established conversion formulas, and SD was back-calculated from reported standard errors or CI when necessary (17).
When primary studies reported >1 eligible comparison (distinct postoperative follow-up time points or separate patient strata), each comparison was treated as an independent effect size when it represented a clinically distinct contrast with separate summary statistics (means and SD). This approach allows the meta-analysis to incorporate all available evidence while preserving the specific clinical context of each comparison.
To account for anticipated between-study heterogeneity, a random-effects model was prespecified. Subgroup analyses were conducted using a mixed-effects approach, in which random-effects models were applied within each subgroup, while differences between subgroups were assessed using a fixed-effect Q_between statistic. Between-study variance (τ²) was estimated using the DerSimonian-Laird method. Sensitivity analyses were performed using the Paule-Mandel, Sidik-Jonkman, and restricted maximum-likelihood estimators, and the Hartung-Knapp-Sidik-Jonkman adjustment was applied to the pooled variance. Statistical heterogeneity was quantified using Cochran's Q statistic (P<0.10), I², τ², and τ. In addition to 95% CI, 95% prediction interval (PI) was calculated for each pooled SMD to estimate the range within which the true effect of a comparable future study was likely to lie.
Robustness of the findings was assessed through several sensitivity analyses, including leave-one-out influence analysis, Baujat plots to identify influential comparisons, comparison with a fixed-effect model, exclusion of studies at higher risk of bias, and reanalysis using alternative effect-size metrics (raw MMSE point change). Potential publication bias and small-study effects were evaluated by visual inspection of funnel plots of SMDs against their standard errors, Egger's weighted regression test, and Begg's rank-correlation test (two-tailed P<0.1) and Duval and Tweedie's trim-and-fill method when asymmetry was detected to estimate the number of potentially missing studies and generate an adjusted pooled effect size. In addition, Rosenthal's and Orwin's fail-safe N statistics were calculated to estimate how many null studies would be required to overturn the overall result.
P<0.05 was considered to indicate a statistically significant difference, and all tests were two-tailed unless otherwise specified (P<0.10 for Cochran's Q and funnel-plot asymmetry tests). CI, PI, and test statistics were based on the t-distribution with k-1 degrees of freedom (df).
The systematic database search identified 1,564 records. Following removal of 312 duplicates, 1,252 titles and abstracts were screened, of which 1,160 were excluded for not meeting the criteria (non-cardiac surgery, pediatric populations or absence of a cognitive outcome; Fig. 1). In total, 72 full-text articles were assessed for eligibility and 64 were excluded for the following reasons: No MMSE data (n=21), review, editorial or conference abstract (n=13), ineligible study design (no original data; n=12), mixed surgical cohorts without extractable cardiac subgroup data (n=10) and duplicate or overlapping populations (n=8). In total, eight studies met the eligibility criteria and were included in the qualitative synthesis (10-16,18), yielding 14 independent comparisons (distinct patient groups, time points, or surgical strata).
All eight studies (10-16,18) were prospective single-center cohorts published between 2005 and 2024; four were conducted in Japan (10-13), with one each in India (16), Sweden (14), China (18), and Malaysia (15). A total of 867 patients (sample size range, 28-280) undergoing on-pump CABG or valve surgery were analyzed. Mean or median age was between 60 and 65 in the Japanese (10-13) and Swedish (14) cohorts and ~50 years in the Chinese valve cohort (18); the overall proportion of male patients was ~70%, but was lower (39%) in the study by Zhang et al (18). All studies assessed MMSE scores pre-operatively and at ≥1 early postoperative time point [within the first postoperative week or at hospital discharge in six studies, 2 weeks in Maekawa et al (13), and 6 weeks in Yazit et al (15)]. Several cohorts also included longer follow-up assessments up to 6 months (Table I) (10). Postoperative cognitive assessment spanned the very early phase (≤1 week), an intermediate window (2 weeks), and a later window (6 weeks-6 months), yielding 14 independent comparisons included in the meta-analysis. Baseline MMSE scores ranged from 26 to 29 points, indicating generally preserved preoperative cognitive function across the populations.
Cardiac surgery was associated with a significant decline in MMSE (Hedges g=-0.60, 95% CI -0.85 to -0.35, P<0.001; Fig. 2). For clinical interpretability, the pooled standardized effect size was translated into an approximate change in raw MMSE points. Using the typical baseline SD reported across the included cohorts (~3 MMSE points), the pooled effect size (g=-0.60) corresponded to an estimated decline of 1-2 points on the 30-point MMSE scale. Between-study heterogeneity was notable (τ²=0.178, τ=0.422; Q=116.4, df=13, P<0.001; I²=88.8%). The 95% PI (-1.56 to 0.36) spanned both negative and slightly positive values, indicating that while most cohorts are expected to show cognitive decline, the inclusion of values above zero suggests that small improvements remain possible in some populations. A fixed-effect model yielded a smaller but significant estimate (g=-0.35, 95% CI -0.43 to -0.27, P<0.001).
Using the prespecified mixed-effects model, patients who developed POCD (eight comparisons) showed a significant decline in MMSE scores (Hedges' g=-0.893, 95% CI -1.258 to -0.527; P<0.001; 95% PI -2.114 to 0.328), whereas patients without POCD (six comparisons) showed a non-significant change (g=-0.274, 95% CI -0.631 to 0.084; P=0.134; 95% PI, -1.517 to 0.970; Fig. 3). Heterogeneity was high in both subgroups (I²=88-89%), but the between-group test showed a significant difference in effect sizes (Q_between=9.08, df=1, P=0.003). Across all 14 comparisons, the pooled mixed-effects estimate was g=-0.576 (95% CI -0.832 to -0.321; P<0.001; 95% PI -1.539 to 0.386), indicating that the overall postoperative decline was driven primarily by the subgroup with clinical POCD.
Sequential leave-one-out sensitivity analysis showed that omission of any single comparison changed the pooled standardized mean difference by <0.08. In every iteration, the pooled estimate remained negative and significant (all P≤0.002), indicating that the overall result was not driven by any individual comparison (Fig. 4). Taken together, these findings support the robustness of the conclusion that cardiac surgery was associated with a significant postoperative decline in MMSE score.
For the primary random-effects model (14 comparisons), the 95% PI ranged from -1.56 to 0.36 SMD units (with the null value falling within the interval), indicating that most future studies of similar design are likely to observe a postoperative decline in MMSE, although a small improvement remains possible in certain cohorts (Fig. 5). The subgroup analyses supported this pattern. Specifically, cohorts consisting primarily of patients with POCD are expected to report a marked cognitive decline, whereas studies including only patients without POCD may plausibly observe outcomes ranging from a modest decline to a modest improvement.
The range of the PI reflects substantial between-study heterogeneity; its predominantly negative distribution supports the overall conclusion that cognitive performance, as measured by the MMSE, generally declined following on-pump cardiac surgery.
Visual inspection of the funnel plot (Fig. 6) suggested an absence of large studies reporting null effects, which was supported by statistical tests. Egger's regression test yielded an intercept of -3.69 (95% CI -6.81 to -0.58; P=0.024), and Begg and Mazumdar's rank-correlation test indicated significant asymmetry (Kendall's τ=-0.43, z=2.14; two-tailed P=0.033). Despite this asymmetry, Duval and Tweedie's trim-and-fill procedure did not identify any potentially missing studies (k_trimmed=0), and the bias-adjusted random-effects estimate was unchanged compared with the original pooled estimate (Hedges' g=-0.598, 95% CI -0.847 to -0.349).
Rosenthal's classic fail-safe N indicated that 431 additional null studies would be required to increase the pooled P-value to >0.05, exceeding the conventional tolerance threshold (5 x k + 10=80). Together, these analyses suggest that although small-study effects may be present, they were unlikely to materially alter the conclusion that cardiac surgery is associated with a significant postoperative decline in MMSE score.
To explore sources of the large between-study heterogeneity (τ²=0.178; I²=~89%), mixed-effects meta-regression analysis was performed, including five a priori clinical moderators: Mean age, cardiopulmonary bypass (CPB) time, study-level prevalence of hypertension and diabetes mellitus, and male sex. The simultaneous (multivariable) model was significant (Q_model=11.22, df=5, P=0.047) and accounted for part of the between-study heterogeneity, although only CPB time was an independent predictor (Table II). Specifically, each 1 min increase in CPB duration was associated with an additional decline of 0.014 SD units in MMSE scores (β=-0.014±0.006, Z=-2.27, P=0.023), corresponding to ~0.9 SD greater decline for 1 h additional bypass time.
Table IIMultivariable meta-regression of mini-mental state examination change after cardiac surgery. |
When each moderator was entered separately (univariate models; Table III), CPB time showed the strongest association and explained ~50% of the between-study variance (R²_analog=0.50; τ² decreased from 0.198 to 0.100; Q=18.68, P=0.0001), whereas age explained ~29% of the heterogeneity (Q=7.23, P=0.007). The remaining covariates contributed little to explaining the variability across studies.
Diagnostic plots and jackknife influence analyses indicated that no single comparison exerted a disproportionate influence on the regression estimates (largest studentized residual=2.10; Cook's distance <1 for all points). Furthermore, no problematic multicollinearity was detected among predictors; the highest correlation was |r|=0.80 between age and hypertension, and all variance inflation factors were ≤1.34 (Fig. 7).
In total, 5/8 studies achieved good methodological quality. All of these were prospective single-center cohorts with clearly stated aims, well-described recruitment, and rigorous multivariable adjustment; for example, Kadoi et al (12) and Kadoi et al (11) used consensus neuropsychology batteries and logistic regression. Maekawa et al (13) and Shiraboina et al (16) were graded as fair, chiefly because short follow-up windows (≤2 weeks) or limited reporting made it unclear whether all relevant confounders were handled; nevertheless, both used validated cognitive outcomes (MMSE + extended batteries) and prospective designs. No study was downgraded for imprecision (every cohort reported effect sizes with either CI or full regression output), and the absence of serious loss to follow-up across studies supported internal validity. External generalizability was highest for the larger cohorts [Yazit et al (15), 188 patients; Kadoi and Goto (10), 280 patients], whereas single-surgeon pilots require cautious extrapolation. Overall, the evidence base was methodologically sound, with minor limitations concentrated in the smaller exploratory studies (Table IV).
The present meta-analysis, which included 14 independent pre/postoperative comparisons and 867 patients, demonstrated a moderate overall decline in MMSE score following on-pump cardiac surgery. Although small improvements cannot be excluded, the 95% PI suggested that most future cohorts may observe some degree of POCD. Despite notable heterogeneity, the pooled estimate remained robust across sensitivity analyses and trim-and-fill procedures, together with a large fail-safe N (431 studies), suggesting that publication bias was unlikely to meaningfully influence the results.
Cognitive outcomes differed markedly according to POCD status. Patients meeting formal POCD criteria experienced a significant decline in MMSE, whereas those without POCD showed only a non-significant change. These findings indicate that the overall POCD observed across studies was largely driven by patients who develop clinically notable neurocognitive impairment.
The pooled standardized effect size corresponded to a decrease of 1-2 points on the 30-point MMSE scale, which is consistent with the magnitude of early postoperative cognitive changes reported in previous studies (19,20). Greaves et al (19) reported cognitive impairment in ~43% of patients immediately following coronary artery bypass surgery, declining to 19% at 6 months but increasing again to 39% after 5 years. The present results, therefore, align with the early POCD reported in large observational cohorts. However, the PI indicated that outcomes may vary across populations, and small improvements may occur in certain cohorts, such as patients with impaired cerebral perfusion who benefit from improved postoperative hemodynamics following revascularization (21).
Several biological mechanisms have been proposed to explain postoperative neurocognitive decline following cardiac surgery (22-24). Current evidence suggests that perioperative neurocognitive disorder is multifactorial and involves interactions between cerebral microembolism, systemic inflammatory activation, and transient cerebral hypoperfusion during CPB (24). Microembolic particles, including air bubbles, fat droplets, platelet aggregates, and fragments of atherosclerotic plaque, may enter the cerebral circulation during aortic manipulation or extracorporeal circulation, leading to occlusion of small cerebral vessels and focal neuronal injury (24). In addition, CPB activates inflammatory pathways through contact between circulating blood and artificial circuit surfaces, resulting in complement activation and the release of pro-inflammatory cytokines such as interleukin-6 and tumor necrosis factor-α. These inflammatory responses may disrupt the blood-brain barrier and promote neuroinflammation, which is a key contributor to POCD (24). Transient cerebral hypoperfusion and ischemia-reperfusion injury may exacerbate neuronal vulnerability and impair synaptic function, contributing to POCD (22-24).
In addition to these established mechanisms, mitochondrial dysfunction may represent a key downstream pathway in postoperative neurocognitive decline (25-30). Surgery, anesthesia, ischemia-reperfusion, and systemic inflammation can impair mitochondrial respiration, decrease ATP production, increase oxidative stress, disrupt calcium homeostasis, and interfere with mitophagy and other mitochondrial quality-control processes (25,30,31). These changes may impair synaptic plasticity and neuronal integrity, thereby contributing to POCD (25). Preclinical and narrative review data further suggest that modulation of mitochondrial dynamics and homeostasis may represent a promising therapeutic direction, although such approaches remain investigational and have not been established in routine perioperative practice (25-28).
Subgroup analysis confirmed that patients meeting POCD criteria experienced notably greater cognitive decline than those without POCD. Notably, the non-POCD subgroup demonstrated a non-significant reduction in MMSE scores, suggesting that subtle cognitive changes may occur in patients who do not meet formal diagnostic thresholds. This is consistent with prior evidence showing that patients undergoing cardiac surgery without overt neurocognitive complications may experience modest postoperative declines in cognitive performance (32). For example, Saczynski et al (32) reported that patients who did not develop postoperative delirium demonstrated an average MMSE reduction of ~2 points in the early postoperative period.
Because the number of available comparisons was relatively small, the present meta-regression analyses were considered exploratory and interpreted with caution to minimize the risk of overfitting. The analysis was conducted using study-level covariates rather than individual patient data; therefore, the observed associations represent ecological associations at the study level and should not be interpreted as causal effects at the individual level. The present meta-regression analysis identified CPB duration as the only significant moderator associated with variability in postoperative MMSE decline. Each additional minute of CPB was associated with a small increase in cognitive impairment (33). Prolonged CPB may increase neurological vulnerability through mechanisms such as increased embolic load, systemic inflammatory activation, and alterations in cerebral perfusion (34). However, CPB duration may also reflect surgical complexity, as longer bypass times typically occur in patients undergoing more complicated procedures or combined operations.
Beyond bypass duration, several patient-level and procedural factors are associated with POCD. In particular, advanced age has consistently been identified as an important risk factor (35,36). Older patients may have decreased cognitive reserve and greater cerebrovascular disease burden, which may increase vulnerability to perioperative cerebral insult (37).
From a clinical perspective, several perioperative strategies have been proposed to mitigate postoperative neurocognitive complications (38-41). Multicomponent perioperative care pathways, typically referred to as delirium prevention bundles, decrease postoperative delirium and may improve broader neurocognitive outcomes (41). These interventions typically include early mobilization, measures to promote normal sleep-wake patterns and maintain patient orientation to their surroundings, adequate pain control, minimization of sedative medications, and prompt removal of unnecessary invasive devices (33). In addition, increasing attention has been directed toward cognitive prehabilitation (42,43), which aims to enhance cognitive reserve before surgery through interventions such as cognitive training, optimization of vascular risk factors, and patient education (38-43). Intraoperative strategies, including monitoring of anesthetic depth and cerebral oxygenation, may also contribute to decreasing neurological injury during cardiac surgery (38-41).
The robustness of the present findings is supported by methodological strengths, including independent dual data extraction, high methodological quality among included studies, the use of both CI and PI, and comprehensive sensitivity analyses. Furthermore, the use of a uniform cognitive outcome measure (MMSE) across all studies allowed direct comparison of cognitive changes across cohorts and avoided the heterogeneity that arises when different neuropsychological batteries are combined.
However, the present study had several limitations. First, substantial residual heterogeneity remained despite moderator analysis, suggesting that additional factors, such as genetic susceptibility, anesthetic depth, and cerebral autoregulation, may influence postoperative cognitive outcomes. Second, follow-up durations were relatively limited, with the longest postoperative assessment occurring at 6 months, preventing evaluation of the long-term cognitive trajectory. Third, effect sizes were derived from reported pre- and postoperative means and SD; because most primary studies did not report the correlation between paired measurements, assumptions regarding within-subject dependence could not be directly verified, which may influence the precision of standardized effect estimates. Fourth, reliance on the MMSE may underestimate subtle cognitive impairments, as patients with mild deficits achieve near-normal total scores, and the test includes only limited assessment of executive function and processing speed, which are commonly affected in POCD. In addition, MMSE performance may be influenced by cultural and educational factors, which may introduce measurement bias when comparing heterogeneous populations across countries and healthcare settings. Fifth, the included studies lacked non-surgical control groups, making it difficult to distinguish cognitive changes attributable specifically to cardiac surgery from those associated with aging, comorbidities, or perioperative hospitalization. Finally, meta-regression analyses were based on study-level data and a relatively small number of comparisons, which limited statistical power and introduced potential ecological bias and residual confounding. The review protocol was not prospectively registered, which may decrease transparency. Variability in diagnostic criteria for POCD across studies may also have introduced misclassification bias. Although publication bias analyses were performed, the small number of included studies requires cautious interpretation because statistical tests for funnel plot asymmetry have limited power when <10 studies are available.
Overall, cardiac surgery is typically associated with moderate postoperative cognitive decline, particularly among patients who develop POCD. Awareness of this risk may support perioperative cognitive monitoring and targeted prevention strategies. Patients at higher risk, especially older adults or those with pre-existing cognitive vulnerability, may benefit from preoperative cognitive screening and structured postoperative follow-up. Early cognitive rehabilitation may also be considered for patients experiencing postoperative cognitive impairment.
The present analysis indicates that on-pump cardiac surgery is associated with a moderate postoperative decline in MMSE score, although cognitive outcomes vary across patients and study populations. Patients who met formal criteria for POCD demonstrated particularly pronounced declines, whereas individuals without POCD showed non-significant changes. The present exploratory analyses also identified longer CPB duration as a study-level factor associated with greater postoperative cognitive decline, although this should be interpreted cautiously given the observational nature of the included studies and the potential for residual confounding.
The present findings contribute to the growing body of evidence that PNDs represent a key clinical concern following cardiac surgery (44-46). From a clinical perspective, awareness of potential postoperative cognitive changes may support improved perioperative counseling, cognitive monitoring, and early identification of patients at higher risk for neurocognitive complications. More broadly, the present study supported the integration of perioperative neurocognitive assessment into cardiac surgical care pathways and highlighted potentially modifiable intraoperative factors that may inform future brain-protective strategies. Future research should focus on strategies aimed at mitigating neurological injury during cardiac surgery, including optimization of CPB management, improved cerebral perfusion monitoring, and the evaluation of perioperative neuroprotective approaches. In addition, longer-term prospective studies, ideally including appropriate non-surgical control groups, are needed to clarify whether postoperative cognitive changes reflect surgery-associated effects, underlying patient vulnerability, or the natural trajectory of cognitive aging. To the best of our knowledge, evidence is still lacking regarding the standardization of cognitive outcome assessment, the role of mechanistic biomarkers and neuroimaging, and the real-world feasibility and effectiveness of preventive interventions in routine perioperative practice. Improved understanding of these mechanisms and risk factors may facilitate better risk stratification, targeted preventive interventions, and improved neurological outcomes for patients undergoing cardiac surgery.
Not applicable.
Funding: The present study was supported by Chronic Disease Management Research Project of National Health Commission Capacity Building and Continuing Education Center (grant no. GWJJMB202510021111), the Tianshan Talents Program for the Cultivation of High-Level Medical and Health Professionals (grant no. TSYC202401B001), the Natural Science Foundation of Xinjiang Province (grant no. 2024D01C176) and the Young Medical Science and Technology Talent Project of Xinjiang Provincial Health Commission (grant no. WJWY-202459).
The data generated in the present study are included in the figures and/or tables of this article.
XL and JWu designed the study, interpreted data, and drafting of the manuscript. ZH interpreted the data. JWa conceived and designed the study, interpretation, and critically revised and finalized the manuscript. XC and JWa confirm the authenticity of all the raw data. HC conceived and designed the study and interpreted data. YY performed the literature review. XC and WY analyzed data. XL and JWu wrote the manuscript. ZH revised the manuscript. JWu supervised the study. JWa provided overall guidance and finalized the manuscript. All authors have reviewed and approved the final manuscript.
Not applicable.
Not applicable.
The authors declare that they have no competing interests.
|
Evered L, Silbert B, Knopman DS, Scott DA, DeKosky ST, Rasmussen LS, Oh ES, Crosby G, Berger M and Eckenhoff RG: Nomenclature Consensus Working Group. Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery-2018. Anesthesiology. 129:872–879. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Evered L, Silbert B, Knopman DS, Scott DA, DeKosky ST, Rasmussen LS, Oh ES, Crosby G, Berger M and Eckenhoff RG: Nomenclature Consensus Working Group. Recommendations for the nomenclature of cognitive change associated with anaesthesia and surgery-2018. Br J Anaesth. 121:1005–1012. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Zhang L, Qiu Y, Zhang ZF, Zhao YF and Ding YM: Current perspectives on postoperative cognitive dysfunction in geriatric patients: Insights from clinical practice. Front Med (Lausanne). 11(1466681)2024.PubMed/NCBI View Article : Google Scholar | |
|
Linassi F, Maran E, De Laurenzis A, Tellaroli P, Kreuzer M, Schneider G, Navalesi P and Carron M: Targeted temperature management in cardiac surgery: A systematic review and meta-analysis on postoperative cognitive outcomes. Br J Anaesth. 128:11–25. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Pas MT, Olde Rikkert M, Bouwman A, Kessels R and Buise M: Screening for mild cognitive impairment in the preoperative setting: A narrative review. Healthcare (Basel). 10(1112)2022.PubMed/NCBI View Article : Google Scholar | |
|
Su Y, Dong J, Sun J, Zhang Y, Ma S, Li M, Zhang A, Cheng B, Cai S, Bao Q, et al: Cognitive function assessed by Mini-mental state examination and risk of all-cause mortality: A community-based prospective cohort study. BMC Geriatr. 21(524)2021.PubMed/NCBI View Article : Google Scholar | |
|
Salis F, Costaggiu D and Mandas A: Mini-mental state examination: Optimal cut-off levels for mild and severe cognitive impairment. Geriatrics (Basel). 8(12)2023.PubMed/NCBI View Article : Google Scholar | |
|
Critical Appraisal Skills Programme: CASP checklists, 2018. Available at: https://casp-uk.net/casp-tools-checklists/. Accessed May 2, 2025. | |
|
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al: The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 372(n71)2021.PubMed/NCBI View Article : Google Scholar | |
|
Kadoi Y and Goto F: Factors associated with postoperative cognitive dysfunction in patients undergoing cardiac surgery. Surg Today. 36:1053–1057. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Kadoi Y, Kawauchi C, Ide M, Kuroda M, Takahashi K, Saito S, Fujita N and Mizutani A: Preoperative depression is a risk factor for postoperative short-term and long-term cognitive dysfunction in patients with diabetes mellitus. J Anesth. 25:10–17. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Kadoi Y, Saito S, Fujita N and Goto F: Risk factors for cognitive dysfunction after coronary artery bypass graft surgery in patients with type 2 diabetes. J Thorac Cardiovasc Surg. 129:576–583. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Maekawa K, Baba T, Otomo S, Morishita S and Tamura N: Low pre-existing gray matter volume in the medial temporal lobe and white matter lesions are associated with postoperative cognitive dysfunction after cardiac surgery. PLoS One. 9(e87375)2014.PubMed/NCBI View Article : Google Scholar | |
|
Veliz-Reissmüller G, Agüero Torres H, van der Linden J, Lindblom D and Eriksdotter Jönhagen M: Pre-operative mild cognitive dysfunction predicts risk for post-operative delirium after elective cardiac surgery. Aging Clin Exp Res. 19:172–177. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Yazit NAA, Juliana N, Hafidz KM, Aziz NASA, Maluin SM, Azmani S, Teng NIMF, Das S and Kadiman S: Exploring cognitive changes in high-risk cardiac patients receiving dexmedetomidine and evaluating the correlation between different cognitive tools: A cohort study. Rev Cardiovasc Med. 25(273)2024.PubMed/NCBI View Article : Google Scholar | |
|
Shiraboina M, Ayya S, Srikanth Y, Kumar R, Durga P and Gopinath R: Predictors of postoperative cognitive dysfunction in adult patients undergoing elective cardiac surgery. Indian J Anaesth. 58:334–336. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Chi KY, Li MY, Chen C and Kang E: Cochrane Taiwan. Ten circumstances and solutions for finding the sample mean and standard deviation for meta-analysis. Syst Rev. 12(62)2023.PubMed/NCBI View Article : Google Scholar | |
|
Zhang Y, Duan B, Wang L, Ye Z, Pan Y, Guo Q and Wang E: Association between the variability of cerebral oxygen saturation during cardiopulmonary bypass and delayed postoperative neurocognitive recovery in cardiac valve surgical patients: A pilot study. Int J Clin Pract. 75(e13651)2021.PubMed/NCBI View Article : Google Scholar | |
|
Greaves D, Psaltis PJ, Ross TJ, Davis D, Smith AE, Boord MS and Keage HAD: Cognitive outcomes following coronary artery bypass grafting: A systematic review and meta-analysis of 91,829 patients. Int J Cardiol. 289:43–49. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Newman MF, Kirchner JL, Phillips-Bute B, Gaver V, Grocott H, Jones RH, Mark DB, Reves JG and Blumenthal JA: Neurological Outcome Research Group and the Cardiothoracic Anesthesiology Research Endeavors Investigators. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med. 344:395–402. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Smith PJ, Browndyke JN, Monge ZA, Harshbarger TB, James ML, Gaca JG, Alexander JH, Berger MM, Newman MF, Milano CA, et al: Longitudinal changes in regional cerebral perfusion and cognition after cardiac operation. Ann Thorac Surg. 107:112–118. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Zhang ZR, Li YZ, Wu XQ, Chen WJ, Xu J, Zhao WH and Gong XY: Postoperative cognitive dysfunction in elderly postcardiac surgery patients: Progress in rehabilitation application research. Front Rehabil Sci. 5(1525813)2024.PubMed/NCBI View Article : Google Scholar | |
|
Hogue CW, Gottesman RF and Stearns J: Mechanisms of cerebral injury from cardiac surgery. Crit Care Clin. 24:83–98, viii-ix. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Xu X, Zhu D, Wu Y, Kuang X, Wang L, Wang X and Shi H: Perioperative neurocognitive disorders in elderly patients undergoing cardiac surgery: Mechanisms, biomarkers, and prevention. J Cardiothorac Vasc Anesth: Jan 21, 2026 (Epub ahead of print) doi: S1053-0770(26)00053-4, 2026. | |
|
Zhang Z, Yang W, Wang L, Zhu C, Cui S, Wang T, Gu X, Liu Y and Qiu P: Unraveling the role and mechanism of mitochondria in postoperative cognitive dysfunction: A narrative review. J Neuroinflammation. 21(293)2024.PubMed/NCBI View Article : Google Scholar | |
|
Liu F, Wu X, Wang Z, Li A, Luo Y and Cao J: Mitochondrial dysfunction in postoperative cognitive dysfunction: From preclinical mechanisms to multimodal diagnostics and precision intervention. Ageing Res Rev. 111(102845)2025.PubMed/NCBI View Article : Google Scholar | |
|
Yang Y, Liu Y, Zhu J, Song S, Huang Y, Zhang W, Sun Y, Hao J, Yang X, Gao Q, et al: Neuroinflammation-mediated mitochondrial dysregulation involved in postoperative cognitive dysfunction. Free Radic Biol Med. 178:134–146. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Ying J, Deng X, Du R, Ding Q, Tian H, Lin Y, Zhou B and Gao W: Mitochondrial modulation treating postoperative cognitive dysfunction neuroprotection via DRP1 inhibition by Mdivi1. Sci Rep. 14(26155)2024.PubMed/NCBI View Article : Google Scholar | |
|
Netto MB, de Oliveira Junior AN, Goldim M, Mathias K, Fileti ME, da Rosa N, Laurentino AO, de Farias BX, Costa AB, Rezin GT, et al: Oxidative stress and mitochondrial dysfunction contributes to postoperative cognitive dysfunction in elderly rats. Brain Behav Immun. 73:661–669. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Ye F, Wei C and Wu A: The potential mechanism of mitochondrial homeostasis in postoperative neurocognitive disorders: An in-depth review. Ann Med. 56(2411012)2024.PubMed/NCBI View Article : Google Scholar | |
|
Pang B, Dong G, Pang T, Sun X, Liu X, Nie Y and Chang X: Emerging insights into the pathogenesis and therapeutic strategies for vascular endothelial injury-associated diseases: Focus on mitochondrial dysfunction. Angiogenesis. 27:623–639. 2024.PubMed/NCBI View Article : Google Scholar | |
|
Saczynski JS, Marcantonio ER, Quach L, Fong TG, Gross A, Inouye SK and Jones RN: Cognitive trajectories after postoperative delirium. N Engl J Med. 367:30–39. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Greaves D, Psaltis PJ, Davis DHJ, Ross TJ, Ghezzi ES, Lampit A, Smith AE and Keage HAD: Risk factors for delirium and cognitive decline following coronary artery bypass grafting surgery: A systematic review and meta-analysis. J Am Heart Assoc. 9(e017275)2020.PubMed/NCBI View Article : Google Scholar | |
|
Zhuang YM, Xu JY, Zheng K and Zhang H: Research progress of postoperative cognitive dysfunction in cardiac surgery under cardiopulmonary bypass. Ibrain. 10:290–304. 2023.PubMed/NCBI View Article : Google Scholar | |
|
Ntalouka MP, Arnaoutoglou E and Tzimas P: Postoperative cognitive disorders: An update. Hippokratia. 22:147–154. 2018.PubMed/NCBI | |
|
Kotekar N, Kuruvilla CS and Murthy V: Post-operative cognitive dysfunction in the elderly: A prospective clinical study. Indian J Anaesth. 58:263–268. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Goto T, Baba T, Yoshitake A, Shibata Y, Ura M and Sakata R: Craniocervical and aortic atherosclerosis as neurologic risk factors in coronary surgery. Ann Thorac Surg. 69:834–840. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Milz S, Holaubek C, Siebel J, Hulde N, Wefer F, Fruend A, Tigges-Limmer K, Gummert J and von Dossow V: Implementation of evidence-based international recommendations reduces postoperative delirium rate in patients undergoing cardiac surgery or interventions: A system-based quality improvement study. Rev Cardiovasc Med. 25(369)2024.PubMed/NCBI View Article : Google Scholar | |
|
Ahmadzadeh S, Duplechin DP, Haynes AT, Hollander AV, Rieger R, Jean Baptiste C, Varrassi G, Shekoohi S and Kaye AD: Evolving clinical management of postoperative delirium: A narrative review. Cureus. 17(e92927)2025.PubMed/NCBI View Article : Google Scholar | |
|
Lau KT, Chiu LCS, Fong JSY, Chan AKM, Ho KM and Lee A: Preoperative cognitive training for the prevention of postoperative delirium and cognitive dysfunction: A systematic review and meta-analysis. Perioper Med (Lond). 13(113)2024.PubMed/NCBI View Article : Google Scholar | |
|
Kotekar N, Shenkar A and Nagaraj R: Postoperative cognitive dysfunction-current preventive strategies. Clin Interv Aging. 13:2267–2273. 2018.PubMed/NCBI View Article : Google Scholar | |
|
He Y, Wang Z, Zhao Y, Han X, Guo K, Sun N and Liu X: Cognitive prehabilitation for older adults undergoing elective surgery: A systematic review and narrative synthesis. Front Aging Neurosci. 16(1474504)2024.PubMed/NCBI View Article : Google Scholar | |
|
Humeidan ML, Reyes JC, Mavarez-Martinez A, Roeth C, Nguyen CM, Sheridan E, Zuleta-Alarcon A, Otey A, Abdel-Rasoul M and Bergese SD: Effect of cognitive prehabilitation on the incidence of postoperative delirium among older adults undergoing major noncardiac surgery: The neurobics randomized clinical trial. JAMA Surg. 156:148–156. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Ji L and Li F: Potential markers of neurocognitive disorders after cardiac surgery: A bibliometric and visual analysis. Front Aging Neurosci. 14(868158)2022.PubMed/NCBI View Article : Google Scholar | |
|
Ren X, Huiqiao L, Wu Y, Zhang T, Chen P, Li L, Zhao G and Wang F: Perioperative neurocognitive disorders: A comprehensive review of terminology, clinical implications, and future research directions. Front Neurol. 16(1526021)2025.PubMed/NCBI View Article : Google Scholar | |
|
Paternò DS, Via L, Putaggio A, Piccolo A, Scibilia G, Lentini M, Maniaci A, Luca F, Giudice ECL and Sorbello M: Perioperative neurocognitive disorders: A narrative review of pathophysiology, prevention, and management strategies. J Clin Med. 15(1253)2026.PubMed/NCBI View Article : Google Scholar |